Question 1

Who are the top researchers at Mapi Pharma (Israel)?

Accepted Answer

Ranked on the quality score, Shai Rubnov, Nadav Bleich Kimelman and Laura Popper lead among researchers whose main affiliation is Mapi Pharma (Israel).

Question 2

What are the most cited papers from Mapi Pharma (Israel)?

Accepted Answer

The most cited paper from Mapi Pharma (Israel) is "Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia" (Ilan Stein, Ahuva Itin, Paz Einat et al., 1998), with 500 citations. Next come "Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype" (280) and "Ero1-Lα plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer" (166).

Question 3

Which research topics does Mapi Pharma (Israel) publish most on?

Accepted Answer

By volume in 2022-now: Mesenchymal stem cell research, CAR-T cell therapy research, Phytochemicals and Antioxidant Activities and Multiple Sclerosis Research Studies.

Question 4

Which keywords describe research at Mapi Pharma (Israel)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Regeneration, Mesenchymal Stem Cells, Epidemiology, Pathogenesis, Differentiation, Immunomodulation, Multipotent and Genomics.

Question 5

Which fields of science does Mapi Pharma (Israel) work in?

Accepted Answer

In all years, 57% of research at Mapi Pharma (Israel) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (22%), Neuroscience (9%). It does 2.0× the world's share of Health Sciences.

Question 6

Is Mapi Pharma (Israel)'s research output growing?

Accepted Answer

Output in 2022-2025 was 57% higher than in 2018-2021.